You can Subscribe to our RSS FEED:
which delivers brain tumor news and additions
to the website via RSS.
Click HERE for details on RSS.
Displaying items 26 to 50 of about 5461
Parents demand new brain cancer drug be made available in Australia
Kazia Therapeutics : PROVIDES PROGRESS UPDATE ON GBM AGILE PIVOTAL STUDY
Musella Foundation Copayment Assistance Program is now open to new and renewal patients!
Introduction to ROON!
Chemotherapy drug temozolomide analog shows promise in treating glioma
Intratumoral oncolytic herpes virus G47? for residual or recurrent glioblastoma: a phase 2 trial
Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma
Regorafenib in Pretreated Patients With Progressive CNS Grade 3 or 4 Gliomas
ERC Granted FDA Fast Track Designation for Sitoiganap in Patients with Recurrent Glioblastoma
Advanced MRI Measurements of Brain Tumors (video)
An implantable ultrasound-powered device for the treatment of brain cancer using electromagnetic fields
Genentech-led team uncovers how cancer cells resist T-cell attack in potential boon to immunotherapy
CORRECTION on " NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma "
The mechanisms of action of Tumor Treating Fields
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma
Musella Foundation Celebrates Glioblastoma Awareness Day by publishing new edition of the "Brain Tumor Guide For The Newly Diagnosed"!
NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
FDA Grants Orphan Drug, Fast Track Designations to CV-01 in Recurrent Glioblastoma
New study finds evidence of Lyme bacteria in brain tissue
National Comprehensive Cancer Network Shares New Recommendations for Treating Children with Brain Tumors
Planning System for the Optimization of Electric Field Delivery using Implanted Electrodes for Brain Tumor Control
Oncolytic Virus Infusion Promising as Brain-Stem Glioma Treatment
Musella Foundation Awards Brain Tumor Research Grants!
SonALAsense Achieves Significant Clinical, Growth and Funding Milestones Toward its Mission to Soundly Defeat Cancer
Share Your Experiences with GBM to Help Others
Brain Tumor News Blast
Click HERE to subscribe!
Copyright © 1993 - 2022 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com